期刊文献+

^(99)Tc^m-3PEG4-RGD用于家兔易损斑块分子显像 被引量:5

^(99)Tc^m-3PEG4-RGD for molecular imaging of vulnerable plaques in rabbits
下载PDF
导出
摘要 目的探讨通过探测兔新生微血管活体评价动脉易损斑块的可行性。方法将15只雄性新西兰大白兔随机分成普食对照组(A组)、易损斑块组(B组)和稳定斑块组(C组),每组5只。于喂养2周后分别进行股动脉分离假手术(A、C组)和腹主动脉球囊拉伤术(B组),之后喂养不同成分饲料。于4、8、12周末静脉注射99 Tcm-3PEG4-RGD,注射后0.5h、1h、2h行SPECT/CT显像及同机CT平扫。4、8周末显像后对3组各处死1只实验兔,12周末处死剩余动物,行离体血管SPECT显像、病理及免疫组化染色分析。结果 3组实验兔注射99 Tcm-3PEG4-RGD后0.5hSPECT/CT图像显示,4周后3组兔腹主动脉区均未见放射性摄取增高,T/NT值差异无统计学意义(F=2.515,P=0.122);8周后B、C组局部放射性摄取增高(F=17.037,P=0.001);12周后B组腹主动脉局部放射性摄取明显高于A、C组(F=43.710,P<0.001)。8、12周末,B、C组腹主动脉中均含有新生微血管,且B组数量明显高于C组。B组兔腹主动脉斑块的AHA动脉粥样硬化分型为Ⅲ型及Ⅳ型,C组为AHAⅡ型。A组腹主动脉中无新生微血管及易损斑块。结论 99 Tcm-3PEG4-RGD分子显像对无创性评价兔动脉斑块稳定性具有一定价值。 Objective To evaluate the feasibility of ^99Tcm-3PEG4-RGD targeted to micro-vessels for detecting vulnerable plaque on rabbits with SPECT/CT imaging. Methods A total of 15 male New Zealand white rabbits were randomly divided into normal diet group (group A, n=5), vulnerable plaque group (group B, n: 5) and stable plaque group (group C, n= 5). The animals were given sham operation separating femoral artery (group A, C) or abdominal aorta balloon injury (group B) 2 weeks after feeding. ^99Tcm-3PEG4-RGD was injected at the end of the 4, 8 and 12 week. SPECT/CT images were captured 0.5, 1 and 2 h after injection. One rabbit was executed at the end of the 4 and 8 week, and the rest were executed at the end of the 12 week in each group, and then vitro SPECT imaging, pathology and immunohistochemistry analysis were performed. Results At the end of the 4 week, no uptake in aorta was observed in all 3 groups, and the difference of target/non-target ratio (T/NT) was not significant among 3 groups 0.5 h after injection (F=2. 515, P=0. 122). At the end of the 8 week, there was certain radioactive uptake in group B and group C (F= 17. 037, P=0. 001). At the end of the 12 week, the uptake in group B was much higher than that in group A and group C (F=43. 710, P〈0. 001). The amount of micro-vessels in group B was significantly higher than that in group C. Histopathology results showed that at the end of the 12 week, AHA atherosclerotic type of rabbits in group B was type]Ⅲ and Ⅳ, while was typeⅡ in group C. There was no vulnerable plaque nor micro-vessels in rabbits of group A. Conclusion ^99 Tcm-3PEG4-RGD has certain value for noninvasively evaluating the stability of arterial plaque in rabbits.
出处 《中国医学影像技术》 CSCD 北大核心 2014年第6期813-817,共5页 Chinese Journal of Medical Imaging Technology
基金 国家自然科学基金(81271613) 北京自然科学基金(7122060)
关键词 易损斑块 体层摄影术 发射型计算机 单光子 新生微血管 ^99Tcm-3PEG4-RGD Vulnerable plaquel Tomography, emission-computed, single-photon Neovascularization^ 99Tcm-3PEG4-RGD
  • 相关文献

参考文献12

  • 1Finn AV, Nakano M, Narula J, et al. Concept of vulnerable/un- stable plaque. Arterioscler Thromb Vasc Biol, 2010,30(7) :1282- 1292.
  • 2Subbotin VM. Neovaseularization of coronary tunica intima (DIT) is the cause of coronary atherosclerosis. Lipoproteins in- vade coronary intima via neovascularization from adventitial vasa vasorum, but not from the arterial lumen: A hypothesis. Theor Biol Med Model, 2012,9:11.
  • 3Burtea C, Laurent S, Murariu O, et al. Molecular imaging of al pha v beta3 integrin expression in atherosclerotic plaques with a mimetic of RGD peptide grafted to Gd-DTPA. Cardiovase Res, 2008,78(1) : 148-157.
  • 4曲海源,徐缓,韩洪波,陈骐,刘静,邓意辉,徐克.α_vβ_3整合素受体靶向性超顺磁性脂质体的建立及体外磁共振观察[J].中国医学影像技术,2009,25(6):969-972. 被引量:5
  • 5Heroux J, Gharib AM, Danthi NS, et al. High-affinity alphavbe- ta3 integrin targeted optical probe as a new imaging biomarker for early atherosclerosis : Initial studies in Watanabe rabbits. Mol Im- aging Biol, 2010,12(1) :2-8.
  • 6Elkhawad M, Rudd JH. Radiotracer imaging of atherosclerotic plaque biology. Cardiol Clin, 2009,27(2):345-354.
  • 7Okane K, Ibaraki M, Toyoshima H, et al. 18F-FDG accumula- tion in atberosclerosis: Use of CT and MR co-registration of tho- racic and carotid arteries. Eur J Nucl Med Mol Imaging, 2006,33 (5) :589-594.
  • 8Wu C, Li F, Niu G, et al. PET imaging of inflammation biomar- kers. Theranostics, 2013,3(7):448-466.
  • 9Moreno PR, Purushothaman KR, Fuster V, et al. Plaque neo vascularization is increased in ruptured atherosclerotic lesions of human aorta: Implications for plaque vulnerability. Circulation, 2004,110(14) :2032-2038.
  • 10王新龙,侯静波.OCT评价新生血管与冠状动脉粥样斑块易损性中的作用[J].国际心血管病杂志,2011,38(6):387-389. 被引量:9

二级参考文献43

  • 1吕国士,许乙凯.脂质体MRI对比剂的研究进展[J].国外医学(临床放射学分册),2006,29(1):1-4. 被引量:3
  • 2杨华,赵建农,张小明.超顺磁性氧化铁微粒在分子影像学中的研究现状[J].国外医学(临床放射学分册),2007,30(4):221-223. 被引量:3
  • 3Avraamides CJ, Garmy-Susini B, Varner JA. Integrins in angiogenesis and lymph angiogenesis. Nat Rev Cancer, 2008,8(8) :604 -617.
  • 4Trikha M, Zhou Z, Nemeth JA, et al. CNTO 95, a fully human monoclonal antibody that inhibits αv integrins, has antitumor and antiangiogenic activity in vivo. Int J Cancer, 2004, 110(3):326- 335.
  • 5Janssen AP, Schiffelers RM, Ten Hagen TL, et al. Peptide-targeted PEG-Liposomes in anti-angiogenie therapy. Int J Pharm, 2003,254(1) : 55-58.
  • 6Temming K, Schiffelers RM, Molema G, et al. RGD-based strategies for selective delivery of therapeutics and imaging agents to the turnout vasculature. Drug Resistance Updates, 2005, 8 (6) : 381 -402.
  • 7Sapra P, Allen TM. Ligand-targeted liposomal anticancer drugs.Prog Lipid Res, 2003,42(5):439-462.
  • 8Geninatti Crich S, Barge A, Battistini E, et al. Magnetic resonance imaging visualization of targeted cells by the internalization of supramolecular adducts formed between avidin and biotinylated Gd3+ chelates. J Biol Inorg Cbem, 2005,10(1) :78-86.
  • 9Aguzzi MS, Giampietri C, Marchis FD, et al. RGDS peptide induces caspase 8 and caspase 9 activation in human endothelial cells. Blood, 2004,103(11) :4180-4187.
  • 10Bertini I, Bianehin F, Calorini L, et al. Persistent contrast enhancement by sterically stabilized paramagnetic liposomes in murine melanoma. Magn Reson Med, 2004,52(3):669-672.

共引文献25

同被引文献33

  • 1杜施霖,王吉耀,陆伟跃.含有精-甘-天冬氨酸序列的环肽与大鼠肝星状细胞体外结合的特性[J].中华肝脏病杂志,2005,13(5):362-365. 被引量:11
  • 2Neufeld G, Cohen T, Gengrinovitch S, et al. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 1999;13(1): 9-22.
  • 3Inoue M, Itoh H, Ueda M, et al. Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: possible pathophysiological significance of VEGF in progression of atherosclerosis. Circulation. 1998;98(20):2108-2116.
  • 4Wolf M, Kettyle E, Sandler L, et al. Obesity and preeclampsia: the potential role of inflammation. Obstet Gynecol. 2001;98(5 Pt 1):757-762.
  • 5Zolota V, Gerokosta A, Melachrinou M, et al. Microvessel density, proliferating activity, p53 and bcl-2 expression in in situ ductal carcinoma of the breast. Anticancer Res. 1999;19(4B):3269-3274.
  • 6Celletti FL, Hilfiker PR, Ghafouri P, et al. Effect of human recombinant vascular endothelial growth factor165 on progression of atherosclerotic plaque. J Am Coll Cardiol. 2001;37(8):2126-2130.
  • 7Sk?lén K, Gustafsson M, Rydberg EK, et al. Subendothelial retention of atherogenic lipoproteins in early atherosclerosis. Nature. 2002;417(6890):750-754.
  • 8Hoefer IE, Timmers L, Piek JJ. Growth factor therapy in atherosclerotic disease-friend or foe. Curr Pharm Des. 2007;13(17):1803-1810.
  • 9Di Marco GS, Kentrup D, Reuter S, et al. Soluble Flt-1 links microvascular disease with heart failure in CKD. Basic Res Cardiol. 2015;110(3):30.
  • 10Youssry I, Makar S, Fawzy R, et al. Novel marker for the detection of sickle cell nephropathy: soluble FMS-like tyrosine kinase-1 (sFLT-1). Pediatr Nephrol. 2015. in press.

引证文献5

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部